Floatz logo

Immunoglobulin G1 (256-Tyrosine,258-Threonine,260-Glutamic Acid), Anti-(Neural Apoptosis-Regulated Proteinase 1) (Human-Mus Musculus Monoclonal Hrp00130 .Gamma.1-Chain), Disulfide With (3-Valine,5-Serine,49-Serine,66-Aspartic Acid) Human-Mus Musculus Monoclonal Hrp00130 .Kappa.-Chain, Dimer

Atherosclerosis

Peking Union Medical College Hospitalmonoclonal_antibodyPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the Atherosclerosis cohort.

Asset / SponsorPhaseRating
Aspirin
Rajaie Cardiovascular Medical and Research Center
Phase 4BBB
Simvastatin
Northern California Institute of Research and Education
Phase 4BBB
Atorvastatin
Erasmus Medical Center
Phase 4BB
Advicor Component Niacin
University of Washington
Phase 4BB
Rosuvastatin
Emory University
Phase 4BB

View all 45 →

Same molecule, other indications

Immunoglobulin G1 (256-Tyrosine,258-Threonine,260-Glutamic Acid), Anti-(Neural Apoptosis-Regulated Proteinase 1) (Human-Mus Musculus Monoclonal Hrp00130 .Gamma.1-Chain), Disulfide With (3-Valine,5-Serine,49-Serine,66-Aspartic Acid) Human-Mus Musculus Monoclonal Hrp00130 .Kappa.-Chain, Dimer is also rated in:

ischemic strokeActive
BB
Indicative · Phase 4
65 / 100
View asset →
cerebral atherosclerosisActive
BB
Indicative · Phase 4
65 / 100
View asset →
non-small cell lung carcinomaActive
B
Indicative · Phase 4
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →